Novartis receives approval from FDA to market Prevacid® 24HR as first and only OTC proton pump inhibitor in original prescription formulation - Video

This approval will provide greater convenience and broader access to an effective treatment optio...  More »

This approval will provide greater convenience and broader access to an effective treatment option to the 50 million Americans1 suffering from frequent heartburn  « Less